Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
20.3%
% of XBI's 119 holdings also in CANC
50.0%
% of CANC's 48 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 2.5% | 2.8% | 2.5% |
|
BLUEPRINT MEDICINES CORP. | 2.2% | 2.9% | 2.2% |
|
EXELIXIS INC | 2.1% | 3.8% | 2.1% |
|
ABBVIE INC | 2.3% | 1.9% | 1.9% |
|
BRIDGEBIO PHARMA, INC. | 1.8% | 4.5% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CANC
|
NATERA INC | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
|
INSMED INC | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.6% |
|
EXACT SCIENCES CORP | 2.5% |
|
BIOGEN IDEC INC | 2.3% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.3% |
|
BIOMARIN PHARMACEUTICAL INC | 2.0% |
XBI Underweight Relative to CANC
|
ELI LILLY & CO | -5.4% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -5.1% |
|
NOVARTIS AG | -4.3% |
 |
ASTRAZENECA PLC | -4.2% |
|
REVOLUTION MEDICINES, INC. | -4.1% |
|
BRISTOL-MYERS SQUIBB CO | -4.0% |
 |
GENMAB A/S SPONSORED ADR | -3.4% |
 |
MERUS N.V. | -3.2% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -3.0% |
|
NUVALENT, INC. CLASS A | -3.0% |